Meng Z - Search Results

1

Establishment and validation of a nomogram model for predicting the survival probability of differentiated thyroid carcinoma patients: a comparison with the eighth edition AJCC cancer staging system.

Zhang R, Xu M, Liu X, Wang M, Jia Q, Wang S, Zheng X, He X, Huang C, Fan Y, Wu H, Xu K, Li D, Meng Z. Zhang R, et al. Among authors: meng z. Endocrine. 2021 Oct;74(1):108-119. doi: 10.1007/s12020-021-02717-x. Epub 2021 Apr 6. Endocrine. 2021. PMID: 33822318

2

Tc-99m sestamibi parathyroid imaging in a rare case of parathyroid lipoadenoma.

Meng Z, Zhang M, Tan J, Zhang Y, Jia Q, Zhang F. Meng Z, et al. Ann Nucl Med. 2009 May;23(3):317-20. doi: 10.1007/s12149-009-0249-1. Epub 2009 Apr 2. Ann Nucl Med. 2009. PMID: 19340525

3

Tc-99m pertechnetate/sestamibi imaging in a case of recurrent parathyroid carcinoma with metabolic bone disorder.

Meng Z, Tan J, Zhang M, Dong F, Jia Q, Zhang F. Meng Z, et al. Clin Nucl Med. 2009 Jul;34(7):479-82. doi: 10.1097/RLU.0b013e3181a7d136. Clin Nucl Med. 2009. PMID: 19542965 No abstract available.

4

Thyrotoxicosis due to functioning metastatic follicular thyroid carcinoma after twelve I-131 therapies.

Tan J, Zhang G, Xu W, Meng Z, Dong F, Zhang F, Jia Q, Liu X. Tan J, et al. Among authors: meng z. Clin Nucl Med. 2009 Sep;34(9):615-9. doi: 10.1097/RLU.0b013e3181b06b2d. Clin Nucl Med. 2009. PMID: 19692828

5

Demonstration of a congenital urine bladder diverticulum by 99mTc-MDP SPET/CT scan in a female with bone metastases.

Meng Z, Tan J, Dong F, Jia Q, Zhang F. Meng Z, et al. Hell J Nucl Med. 2009 Sep-Dec;12(3):276-8. Hell J Nucl Med. 2009. PMID: 19936344

6

An improved method for measurement of target-to-background ratio in assessing mediastinal lesions on 18F-FDG coincidence SPECT/CT imaging.

Wang P, Meng Z, Tan J, Jia Q, Zhang F. Wang P, et al. Among authors: meng z. Nucl Med Commun. 2010 May;31(5):398-404. doi: 10.1097/MNM.0b013e328336bc4a. Nucl Med Commun. 2010. PMID: 20084038

7

Clinical implications of brown tumor uptake in whole-body 99mTc-sestamibi scans for primary hyperparathyroidism.

Meng Z, Zhu M, He Q, Tian W, Zhang Y, Jia Q, Tan J. Meng Z, et al. Nucl Med Commun. 2011 Aug;32(8):708-15. doi: 10.1097/MNM.0b013e328347b582. Nucl Med Commun. 2011. PMID: 21613966

8

Asymptomatic rib cavernous hemangioma.

Jia Q, Meng Z, Zhou Q, Li D, Zhang Y, Tan J. Jia Q, et al. Among authors: meng z. Clin Nucl Med. 2011 Dec;36(12):1112-4. doi: 10.1097/RLU.0b013e31821c9ad4. Clin Nucl Med. 2011. PMID: 22064083 No abstract available.

9

Nuclear factor-kappa B inhibition can enhance apoptosis of differentiated thyroid cancer cells induced by 131I.

Meng Z, Lou S, Tan J, Xu K, Jia Q, Zheng W. Meng Z, et al. PLoS One. 2012;7(3):e33597. doi: 10.1371/journal.pone.0033597. Epub 2012 Mar 16. PLoS One. 2012. PMID: 22438958 Free PMC article.

10

Nuclear factor-kappa B inhibition can enhance therapeutic efficacy of 131I on the in vivo management of differentiated thyroid cancer.

Meng Z, Lou S, Tan J, Xu K, Jia Q, Zheng W, Wang S. Meng Z, et al. Life Sci. 2012 Dec 10;91(23-24):1236-41. doi: 10.1016/j.lfs.2012.09.026. Epub 2012 Oct 12. Life Sci. 2012. PMID: 23069579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,040 results

Search Page

Filters